U.S. HOUSE RESOLUTION DEEMS FDA’s ESTRIOL “NOT IN THE PUBLIC INTEREST” POLICY ON
Tell your members of Congress:
Support the Resolution to Protect Women’s Access to BHRT!
U.S. House Representatives Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) introduced a bipartisan Sense of the Congress resolution yesterday to counter the efforts of the FDA and Wyeth against compounded bio-identical hormones that contain estriol. H. Con. Res. 342 raises serious concern over the recent move by FDA to ban the use of estriol, and asks for its reversal. Reps. Ross and Emerson were joined by fellow Representatives: Tammy Baldwin (D-Wis.), Michael Burgess (R-Texas), John Carter (R-Texas), Sam Farr (D-Calif.) and Gabrielle Giffords (D-Ariz.).
This is a HUGE step in the right direction!
The resolution also calls on the need of FDA to “respect the physician-patient relationship” and recognizes that doctors, not the FDA, are in the best position to “determine which medications are appropriate for their patients.” It also points out that the “FDA has acknowledged that it is unaware of any adverse events” associated with the use of estriol over the past three decades. To see a copy of the resolution and follow its progress, click here.
We applaud the thousands of you who have written letters to your members of Congress already on this issue… but even if you have already written to your members of Congress, WE NEED YOUR HELP AGAIN!
CLICK HERE today to tell your members of Congress: Protect My Access to BHRT and Sponsor H. Con. Res. 342!